Opportunities, challenges and best practices for capital raising in times of uncertainty
The capital needs of life science companies are unrelenting, even in the best of times. A panel of experts from Danforth, Locust Walk and Mintz held a virtual conversation and Q&A on the following subjects:
- The impacts of Covid-19 on the capital raising process
- Implications for private companies and IPO outlook
- Adjusting to virtual processes: presentations, negotiations, due diligence
- Accessibility of investors and market appetite looking ahead